Yusuke Hatakawa

Mr. Yusuke Hatakawa


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YSYuko Sakaguchi
Yuko Sakaguchi
TAToshifumi Akizawa
Toshifumi Akizawa
MKMotomi Konishi
Motomi Konishi
YHYusuke Hatakawa
Yusuke Hatakawa
HTHidenao Toyoda
Hidenao Toyoda
Toshifumi AkizawaToshifumi Akizawa
Toshifumi Akizawa

17 January 2018 in Preprints.org
Verified
Preprint
Open access
PDF file
TAToshifumi Akizawa
Toshifumi Akizawa
MKMotomi Konishi
Motomi Konishi
MTMasanari Taniguchi
Masanari Taniguchi
YHYusuke Hatakawa
Yusuke Hatakawa
Toshifumi AkizawaToshifumi Akizawa
Toshifumi Akizawa
After screening nearly 1000 synthetic peptides, a synthetic peptide termed JAL-AK22 (KYEGHWYPEKPYKGSGFRCIHI) derived from the BoxA domain in Tob1 protein was found to activate both unfolded and folded proMMP-7. In addition, JAL-AK22 showed auto-proteolytic activity. Interestingly, the smaller derivative of JAL-AK22 termed JAL-TA9 (YKGSGFRMI) also possessed auto-proteolytic activity and cleaved 2 fragment peptides (MMP18-33 and MMP18-40) derived from the prodomain of proMMP-7 under physiological conditions. These proteolytic activities were inhibited by AEBSF, a serine protease inhibitor. Our results demonstrate that a small synthetic peptide consisting of only 9 amino acids has serine protease-like activity and activates proMMP-7 by cleaving the prodomain region. We thus propose calling small peptides possessing with protease-like activity Catalytides (catalytic peptides). We expect that our findings will stimulate the development of novel Catalytides and related applications.